Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Article
|
![]() |
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple MyelomaJournal of clinical oncology, 2018-08, Vol.36 (22), p.2267-2280 [Peer Reviewed Journal]2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.77.8084 ;PMID: 29812997Full text available |
22 |
Material Type: Article
|
![]() |
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon CancerCancer research (Chicago, Ill.), 2019-01, Vol.79 (1), p.146-158 [Peer Reviewed Journal]2018 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-18-0014 ;PMID: 30401711Full text available |
23 |
Material Type: Article
|
![]() |
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice GuidelinesAnnals of oncology, 2021-06, Vol.32 (6), p.801-805 [Peer Reviewed Journal]2021 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.02.014 ;PMID: 33716105Full text available |
24 |
Material Type: Article
|
![]() |
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeClinical cancer research, 2020-01, Vol.26 (2), p.487-504 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-19-1868 ;PMID: 31636098Full text available |
25 |
Material Type: Article
|
![]() |
Targeting Autophagy in Cancer: Recent Advances and Future DirectionsCancer discovery, 2019-09, Vol.9 (9), p.1167-11812019 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-19-0292 ;PMID: 31434711Full text available |
26 |
Material Type: Article
|
![]() |
Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical ImagingClinical cancer research, 2019-06, Vol.25 (11), p.3266-3275 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-2495 ;PMID: 31010833Full text available |
27 |
Material Type: Article
|
![]() |
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of oncology, 2016-09, Vol.27 (suppl 5), p.v38-v49 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw350 ;PMID: 27664260Full text available |
28 |
Material Type: Article
|
![]() |
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid TumorsClinical cancer research, 2021-09, Vol.27 (17), p.4685-4689 [Peer Reviewed Journal]2021 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-21-0327 ;PMID: 34083238Full text available |
29 |
Material Type: Article
|
![]() |
Tumor Mutational Burden as a Predictive Biomarker in Solid TumorsCancer discovery, 2020-12, Vol.10 (12), p.1808-1825ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.CD-20-0522 ;PMID: 33139244Full text available |
30 |
Material Type: Article
|
![]() |
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular CarcinomaJournal of clinical oncology, 2018-07, Vol.36 (19), p.1913-1921 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.0892 ;PMID: 29498924Full text available |
31 |
Material Type: Article
|
![]() |
TIP: A Web Server for Resolving Tumor Immunophenotype ProfilingCancer research (Chicago, Ill.), 2018-12, Vol.78 (23), p.6575-6580 [Peer Reviewed Journal]2018 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-18-0689 ;PMID: 30154154Full text available |
32 |
Material Type: Article
|
![]() |
Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter StudyClinical cancer research, 2019-06, Vol.25 (12), p.3538-3547 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-3190 ;PMID: 30842125Full text available |
33 |
Material Type: Article
|
![]() |
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)Journal of clinical oncology, 2022-09, Vol.40 (25), p.JCO2102660-2933 [Peer Reviewed Journal]2022 by American Society of Clinical Oncology 2022 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.02660 ;PMID: 35576508Full text available |
34 |
Material Type: Article
|
![]() |
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in GlioblastomaClinical cancer research, 2018-09, Vol.24 (17), p.4175-4186 [Peer Reviewed Journal]2018 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-17-1846 ;PMID: 29437767Full text available |
35 |
Material Type: Article
|
![]() |
The Intersection between Tumor Angiogenesis and Immune SuppressionClinical cancer research, 2019-09, Vol.25 (18), p.5449-5457 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-1543 ;PMID: 30944124Full text available |
36 |
Material Type: Article
|
![]() |
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineJournal of clinical oncology, 2021-03, Vol.39 (7), p.840-859 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03237 ;PMID: 33405943Full text available |
37 |
Material Type: Article
|
![]() |
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY ProjectJournal of clinical oncology, 2022-10, Vol.40 (29), p.JCO2102614-3418 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.21.02614 ;PMID: 35605179Full text available |
38 |
Material Type: Article
|
![]() |
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T CellsCancer discovery, 2017-12, Vol.7 (12), p.1404-14192017 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.CD-17-0698 ;PMID: 29025771Full text available |
39 |
Material Type: Article
|
![]() |
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR -Mutated Lung CancerJournal of clinical oncology, 2020-01, Vol.38 (2), p.124-136 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.01154 ;PMID: 31411950Full text available |
40 |
Material Type: Article
|
![]() |
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerCancer discovery, 2018-09, Vol.8 (9), p.1112-11292018 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-18-0349 ;PMID: 29853643Full text available |